Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?
Ferrone C, Tang L, Tomlinson J, Gonen M, Hochwald S, Brennan M, Klimstra D, Allen P. Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified? Journal Of Clinical Oncology 2007, 25: 5609-5615. PMID: 18065733, DOI: 10.1200/jco.2007.12.9809.Peer-Reviewed Original ResearchConceptsDisease-specific survivalPancreatic endocrine neoplasmsConcordance indexWHO classificationAssociated with 5-year disease-specific survivalEndocrine neoplasmsMedian follow-up timeSingle-institution studyAccurate prognostic informationEarly stage tumorsProspective databaseDistant metastasisStage tumorsTumor sizeTumor stageMedian agePrognostic valuePrognostic strengthOperative treatmentPrognostic informationMitotic rateWHO systemTumorInfluence of stageGrading systemPancreatic neuroendocrine tumors: Can the WHO staging system be simplified
Ferrone C, Tang L, Tomplinson J, Klimstra D, Coit D, Brennan M, Allen P. Pancreatic neuroendocrine tumors: Can the WHO staging system be simplified. Journal Of Clinical Oncology 2007, 25: 15038-15038. DOI: 10.1200/jco.2007.25.18_suppl.15038.Peer-Reviewed Original ResearchPancreatic endocrine neoplasmsDisease-specific survivalAssociated with survivalMetastatic diseaseTumor stageWorld Health OrganizationPrognostic value of stageEvidence of metastatic diseasePresence of nodal metastasesInfluence of tumor stageLow grade diseaseDistant metastatic diseaseIntermediate grade tumorsLow-grade tumorsEarly stage tumorsWorld Health Organization staging systemAccurate prognostic informationGrade tumorsNodal metastasisGrade diseasePrimary tumorDisease recurrencePositive nodesPrognostic factorsStage tumors
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply